Brenda Thompson: Daily

Chinese auto giant GAC nearly tripled its exports in two years. Its secret? A hyper-localized strategy that is challenging incumbents worldwide.

Intelligent Bio Solutions raised crucial capital for its fingerprint drug test, but the deal's structure sent shares tumbling amid shareholder dilution fears.

A new strategic partnership aims to dominate the APAC market by integrating displays and AI cameras, promising a frictionless future for meeting rooms.

Amid national rollbacks in equity funding, one Selma-based group expanded its reach, awarding its 1,000th joy grant and proving investment is resistance.

With a new HQ and $2M in contracts, Taoping is leveraging AI and government policy to modernize China's aging elevators, but faces investor scrutiny.

A Vikings-Packers showdown becomes a lifeline for Minnesotans as Land O'Lakes pledges one ton of food for every point scored, fighting winter hunger.

A critical labor dispute at Canada’s largest propane export terminal is over, but not before testing the resilience of a key global energy supply chain.

With a promising schizophrenia drug stalled by FDA requirements and finances tight, Reviva Pharmaceuticals' upcoming presentation is more than just a talk.

Metallis Resources adds a renowned gold-finder to its team to unlock a historic, high-grade Idaho property rich in gold, silver, and critical minerals.

A major order for advanced semiconductor equipment will fuel a European firm's expansion, powering next-gen AI data centers and LiDAR systems.

The CEO of Genenta Science now owns 10% of the company, all bought on the open market. What does this bold insider move signal for its cancer therapy?

A new standing wheelchair module offers unprecedented height, blending advanced engineering with profound health and social benefits for users.

A new pharma-tech alliance aims to leverage quantum computing and AI to create safer opioids, but the non-binding deal faces significant hurdles.

How ONAR Holding's newly acquired agency, JUICE, used AI to shatter holiday sales records, validating a high-stakes M&A strategy for investors.

A long-time innovator at the foundation, Cory Anderson steps into the CEO role with a vision to accelerate economic mobility for Arkansas's families.

A new study reveals a tissue allograft, AmchoPlast™, triples healing rates for diabetic foot ulcers, offering a major breakthrough for a common complication.

A Chinese startup's tiny new heart pump enters human trials, aiming to disrupt a billion-dollar market and solve a massive unmet need in cardiac care.

Tiziana's CEO doubles down with a major share purchase, signaling deep faith in a novel MS drug, even as market signals send mixed messages.

A positive EU opinion for Sobi's Aspaveli could bring the first-ever targeted treatment for two rare kidney diseases, shaking up a market desperate for innovation.

Lightbeam's new NCQA prevalidation isn't just a certificate. It's a strategic move reshaping compliance, patient outcomes, and the health tech market.